Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Patrick W Serruys
  • ,
  • Yoshinobu Onuma
  • ,
  • John A Ormiston
  • ,
  • Bernard de Bruyne
  • ,
  • Evelyn Regar
  • ,
  • Dariusz Dudek
  • ,
  • Leif Thuesen, Denmark
  • Pieter C Smits
  • ,
  • Bernard Chevalier
  • ,
  • Dougal McClean
  • ,
  • Jacques Koolen
  • ,
  • Stephan Windecker
  • ,
  • Robert Whitbourn
  • ,
  • Ian Meredith
  • ,
  • Cécile Dorange
  • ,
  • Susan Veldhof
  • ,
  • Karine Miquel-Hebert
  • ,
  • Richard Rapoza
  • ,
  • Hector M García-García, Denmark
  • Centre for Quantum Geometry of Moduli Spaces
  • The Department of Cardiological Medicine B
The first generation of the bioresorbable everolimus drug-eluting vascular scaffold showed signs of shrinkage at 6 months, which largely contributed to late luminal loss. Nevertheless, late luminal loss was less than that observed with bare metal stents. To maintain the mechanical integrity of the device up to 6 months, the scaffold design and manufacturing process of its polymer were modified.
Original languageEnglish
JournalCirculation
Volume122
Issue22
Pages (from-to)2301-12
Number of pages12
ISSN0009-7322
DOIs
Publication statusPublished - 30 Nov 2010

    Research areas

  • Absorbable Implants, Aged, Coronary Angiography, Coronary Stenosis, Coronary Vessels, Drug-Eluting Stents, Female, Follow-Up Studies, Humans, Male, Middle Aged, Polymers, Retrospective Studies, Sirolimus, Time Factors, Tissue Scaffolds, Tomography, Optical Coherence, Treatment Outcome

See relations at Aarhus University Citationformats

ID: 34232275